This test checks how well your blood can stop red blood cells from clumping together when they are exposed to a specific virus. It's a way doctors can see if your body has antibodies to fight that particular virus.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
A hemagglutination inhibition (HI) test is a laboratory blood test that measures antibodies against certain viruses, most often influenza. Some viruses, including flu, carry a surface protein called hemagglutinin that makes red blood cells clump together. In the lab, a small amount of your serum (the liquid part of blood) is mixed with the virus. If your blood contains antibodies against that virus, they block the clumping. The lab repeats this across a series of increasingly diluted samples, and the result, called a titer, is the most diluted sample that still blocks clumping. A titer of 1:40 means the antibodies still worked when the serum was diluted 40 times. HI testing is used mainly in influenza vaccine studies, flu surveillance and research, where it remains the standard way to measure antibody responses to flu infection and vaccination. It has also been used to check immunity to rubella and mumps, though many labs now use a different method called an enzyme immunoassay (EIA). Because it measures the body's antibody response rather than the virus itself, it shows past exposure or vaccination, not whether a virus is present right now.
Most blood tests, including this one, need no special preparation such as fasting. Tell the person ordering the test about the medicines you take, but do not stop any medicine unless you are specifically told to. If the purpose is to show a recent infection, you may be asked to give two samples: one early and a second several weeks later. A rise of four times or more in the titer between the two samples is the usual sign of a recent infection, so the second visit matters for getting an answer.
A health care worker cleans the skin, usually on the inside of the arm, and uses a small needle to draw blood from a vein into a tube. You may feel a brief sting as the needle goes in or comes out. The draw usually takes less than five minutes, and no sedation is involved. The testing itself happens later in the laboratory, where your serum is diluted step by step and mixed with the virus and red blood cells.
A small bandage covers the needle site, and you can return to normal activities right away. Mild soreness or a small bruise may appear and usually fades quickly. Interpreting the result depends on why the test was done. For influenza, higher titers are linked to a lower risk of infection, and a titer of about 1:40 has long been used as a benchmark associated with roughly a 50% reduction in risk across a group of people. It is not a guarantee for any individual, and researchers have not settled on a firm protective cutoff. HI titers account for only part of the protection a flu vaccine provides, so a low titer does not mean a vaccine did nothing. For paired samples, a fourfold rise supports a recent infection, although people who already had high antibody levels may not show that rise even when infected.
The physical risks come only from the blood draw: slight pain or bruising at the needle site, which usually resolves quickly. The more important limitations concern what the result can tell you. HI measures only antibodies aimed at one part of the virus's surface protein, so it gives a partial view of immunity. It is also less sensitive than enzyme immunoassays for some viruses. In one large comparison of health care workers, HI labeled about a third as lacking mumps antibodies, while EIA found most of them did have antibodies. A negative HI result for immunity can therefore lead to an unnecessary repeat test or vaccination, and results can vary between laboratories using different methods.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Hemagglutination Inhibition Test, what to expect, or ask the community a question.